For example, benzalkonium chloride, a common preservative, is ototoxic and therefore potentially harmful if introduced into the vestibular or cochlear structures
Am J Sports Med, 39(11), 25072515
6.1.2 WILLOW study (phase II clinical trial) 6.1.2.1 Study design and population The WILLOW study represented a pivotal Phase II clinical trial of brensocatib in bronchiectasis patients ( The study recruited 416 patients total, with 256 patients meeting inclusion criteria completing randomization, allocated to placebo group (87 patients), 10 mg brensocatib group (82 patients), and 25 mg brensocatib group (87 patients)
Real Longevity Strategy: Peptides are not a replacement for sleep, resistance training, protein intake, metabolic health, hormone assessment, and inflammation control
Smaller liposomes, typically in the nanometre range, tend to penetrate the skin more effectively due to their ability to navigate its various barriers